Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 12, 2024
Outer
membrane
vesicles
(OMVs)
and
exosomes
are
essential
mediators
of
host-pathogen
interactions.
Elucidating
their
mechanisms
action
offers
valuable
insights
into
diagnosing
treating
infectious
diseases
cancers.
However,
the
specific
interactions
Helicobacter
pylori
(
H.
)
with
host
cells
via
OMVs
in
modulating
immune
responses
have
not
been
thoroughly
investigated.
This
review
explores
how
these
elicit
inflammatory
immunosuppressive
environment,
facilitate
pathogen
invasion
cells,
enable
evasion
defenses,
thereby
contributing
to
progression
gastric
extra-gastric
disseminated
through
bloodstream.
Furthermore,
discusses
challenges
future
directions
for
investigating
exosomes,
underscoring
potential
as
therapeutic
targets
-associated
diseases.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 28, 2024
,
a
globally
prevalent
pathogen
Group
I
carcinogen,
presents
formidable
challenge
in
gastric
cancer
prevention
due
to
its
increasing
antimicrobial
resistance
and
strain
diversity.
This
comprehensive
review
critically
analyzes
the
limitations
of
conventional
antibiotic-based
therapies
explores
cutting-edge
approaches
combat
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 12, 2024
Outer
membrane
vesicles
(OMVs)
and
exosomes
are
essential
mediators
of
host-pathogen
interactions.
Elucidating
their
mechanisms
action
offers
valuable
insights
into
diagnosing
treating
infectious
diseases
cancers.
However,
the
specific
interactions
Helicobacter
pylori
(
H.
)
with
host
cells
via
OMVs
in
modulating
immune
responses
have
not
been
thoroughly
investigated.
This
review
explores
how
these
elicit
inflammatory
immunosuppressive
environment,
facilitate
pathogen
invasion
cells,
enable
evasion
defenses,
thereby
contributing
to
progression
gastric
extra-gastric
disseminated
through
bloodstream.
Furthermore,
discusses
challenges
future
directions
for
investigating
exosomes,
underscoring
potential
as
therapeutic
targets
-associated
diseases.